ClinConnect ClinConnect Logo
Search / Trial NCT06541561

Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy

Launched by WEST CHINA HOSPITAL · Aug 2, 2024

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called transcutaneous electrical acupoint stimulation (TEAS) to see how it affects pain and recovery after surgery for pancreatic cancer. The goal is to find out if this method can help patients feel less pain after a surgery called pancreatectomy, which involves removing part of the pancreas.

To participate in this trial, you need to be between the ages of 18 and 80 and scheduled for a pancreatectomy. However, certain people won’t be eligible, such as those with a history of epilepsy or certain heart devices, and those who are pregnant or breastfeeding. If you join the study, you can expect to receive TEAS during your recovery, and the researchers will monitor your pain levels and overall recovery. It's important to note that this trial is not yet recruiting participants, so there will be more information available when it starts.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-80 years old; ASA physical status class I - III; Patients scheduled for pancreatectomy.
  • Exclusion Criteria:
  • Have a history of epilepsy; Rash or local infection over the acupoint stimulation skin area; Pregnancy or breastfeeding; Mental retardation, psychiatric, or neurological disease; Inability to comprehend the numeric rating scale (NRS); Implantation of a cardiac pacemaker, cardioverter, or defibrillator; Chronic opioid use; Metastases in other organs; Have a history of Transcutaneous Electrical Acupuncture Stimulation (TEAS) or electroacupuncture treatment in the past or recently;

About West China Hospital

West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Luo Fengming, PhD

Principal Investigator

West China Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported